Overview
- 96 inspections across 63 sites are on record.
- 192 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2014-05-07.
At a glance
Inspections
96
Sites
63
Observations
192
Career since
Jan 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Boehringer Ingelheim Chemicals Inc | 7 May 2014 | Human Drugs | |
| Afton Scientific, LLC | 25 Apr 2014 | Human Drugs | View 483 → |
| Bora Pharmaceuticals Injectables Inc | 9 Apr 2014 | Human Drugs | View 483 → |
| Mylan Pharmaceuticals Inc | 21 Mar 2014 | Human Drugs | View 483 → |
| Fareva Richmond, Inc. | 7 Mar 2014 | Human Drugs | On file |
Sites inspected
Boehringer Ingelheim Chemicals IncPetersburg, United States1 insp.
Afton Scientific, LLCCharlottesville, United States1 insp.
Bora Pharmaceuticals Injectables IncBaltimore, United States1 insp.
Mylan Pharmaceuticals IncMorgantown, United States1 insp.
Fareva Richmond, Inc.Henrico, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Ernest Bizjak17 shared
Rachel C Harrington6 shared
Nebil A Oumer6 shared
Brian R Yaun5 shared
Jonathan W Chapman3 shared
Carrie L Doupnik3 shared
Joey C West3 shared
Luis M Burgos Medero3 shared
Paula J Bretz2 shared
Dianne H Milazzo2 shared
Full investigator report
Get the verbatim findings behind Brooke K Higgins' 192 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site